Inclusion Criteria:  An individual who corresponds to any of the following:  Ovarian cancer patients after initial chemotherapy (maintenance therapy) Patients with platinum antineoplastic drug sensitive recurrent ovarian cancer (maintenance therapy) Recurrent ovarian cancer with platinum-sensitive homologous recombination repair defects.  Exclusion Criteria:  Has a history of hypersensitivity to any of the ingredients of this drug.